Puri, Pankaj ; Anand, Anil C. ; Saraswat, Vivek A. ; Acharya, Subrat K. ; Dhiman, Radha K. ; Aggarwal, Rakesh ; Singh, Shivram P. ; Amarapurkar, Deepak ; Arora, Anil ; Chhabra, Mohinish ; Chetri, Kamal ; Choudhuri, Gourdas ; Dixit, Vinod K. ; Duseja, Ajay ; Jain, Ajay K. ; Kapoorz, Dharmesh ; Kar, Premashis ; Koshy, Abraham ; Kumar, Ashish ; Madan, Kaushal ; Misra, Sri P. ; Prasad, Mohan V.G. ; Nagral, Aabha ; Puri, Amarendra S. ; Jeyamani, R. ; Saigal, Sanjiv ; Sarin, Shiv K. ; Shah, Samir ; Sharma, P.K. ; Sood, Ajit ; Thareja, Sandeep ; Wadhawan, Manav (2014) Consensus Statement of HCV Task Force of the Indian National Association for Study of the Liver (INASL). Part I: Status Report of HCV Infection in India Journal of Clinical and Experimental Hepatology, 4 (2). pp. 106-116. ISSN 09736883
PDF
478kB |
Official URL: http://doi.org/10.1016/j.jceh.2014.05.006
Related URL: http://dx.doi.org/10.1016/j.jceh.2014.05.006
Abstract
Globally, around 150 million people are infected with hepatitis C virus (HCV). India contributes a large proportion of this HCV burden. The prevalence of HCV infection in India is estimated at between 0.5% and 1.5%. It is higher in the northeastern part, tribal populations and Punjab, areas which may represent HCV hotspots, and is lower in western and eastern parts of the country. The predominant modes of HCV transmission in India are blood transfusion and unsafe therapeutic injections. There is a need for large field studies to better understand HCV epidemiology and identify high-prevalence areas, and to identify and spread awareness about the modes of transmission of this infection in an attempt to prevent disease transmission.
Item Type: | Article |
---|---|
Source: | Copyright of this article belongs to Elsevier Inc. |
Keywords: | hepatitis C virus, chronic hepatitis, epidemiology |
ID Code: | 128937 |
Deposited On: | 22 Nov 2022 09:38 |
Last Modified: | 22 Nov 2022 09:38 |
Repository Staff Only: item control page